Bio-Thera and Richter Execute Exclusive Commercialization Agreement for BAT2206, a Proposed Stelara® Biosimilar, for EU countries, UK, Switzerland and other selected countries

GUANGZHOU, China and BUDAPEST, Hungary, Oct. 9, 2024 /PRNewswire/ — Bio-Thera Solutions (688177:SH; “Bio-Thera”), a commercial-stage biopharmaceutical company developing a pipeline of innovative therapies and biosimilars, and Gedeon Richter (“Richter”) announce today they have reached an…